Inventor · disambiguated record
Francesco Parlati
Also filed as: PARLATI FRANCESCO
21 granted patents·10 pending applications·250 citations·filing 2004–2021
95Inventor score
Files withCALITHERA BIOSCIENCES INC10ONYX THERAPEUTICS INC9CLEAVE BIOSCIENCES INC4SHENK KEVIN D3PARLATI FRANCESCO2
Top patents by PatentIndex Score
31 records- 0198US7691852B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2007·Granted Apr 6, 2010·65 cites·4 claims
- 0297US8431571B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Apr 30, 2013·33 cites·46 claims
- 0397US8357683B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2011·Granted Jan 22, 2013·34 cites·22 claims
- 0496US8080576B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·37 cites·30 claims
- 0596US8080545B2Compounds for enzyme inhibitionSHENK KEVIN D·Filed 2010·Granted Dec 20, 2011·35 cites·17 claims
- 0690US8609654B1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Granted Dec 17, 2013·8 cites·60 claims
- 0786US9687485B2Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2015·Granted Jun 27, 2017·11 cites·17 claims
- 0885US9062026B2Fused pyrimidines and substituted quinazolines as inhibitors of p97CLEAVE BIOSCIENCES INC·Filed 2013·Granted Jun 23, 2015·6 cites·3 claims
- 0985US7741432B2Substrate for Rpn11 enzymatic activityPROTEOLIX INC·Filed 2006·Granted Jun 22, 2010·8 cites·28 claims
- 1083US10258619B2Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2016·Granted Apr 16, 2019·4 cites·20 claims
- 1177US10441587B2Treatment of lung cancer with inhibitors of glutaminaseCALITHERA BIOSCIENCES INC·Filed 2016·Granted Oct 15, 2019·3 cites·12 claims
- 1276US8765745B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted Jul 1, 2014·1 cites·100 claims
- 1375US10278968B2Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2017·Granted May 7, 2019·3 cites·7 claims
- 1474US10010554B2Fused pyrimidines as inhibitors of P97 complexCLEAVE BIOSCIENCES INC·Filed 2016·Granted Jul 3, 2018·1 cites·25 claims
- 1571US9475824B2Fused pyrimidines as inhibitors of p97 complexCLEAVE BIOSCIENCES INC·Filed 2013·Granted Oct 25, 2016·1 cites·14 claims
- 1666US2014100169A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1766US2014080753A1Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1865US8735441B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2012·Granted May 27, 2014·0 cites·26 claims
- 1965US2008039629A1Benzothniazole compositions and their use as ubiquition ligation inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2065US2021361649A1Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2021·Application pending·0 cites
- 2163US10940148B2Combination therapy with glutaminase inhibitors and immuno-oncology agentsCALITHERA BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 2261US9657058B2Compounds for enzyme inhibitionONYX THERAPEUTICS INC·Filed 2015·Granted May 23, 2017·0 cites·15 claims
- 2361US2005130974A1Benzothiazole compositions and their use as ubiquitin ligase inhibitorsRIGEL PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2455US8697837B2Substrate for Rpn 11 enzymatic activityPARLATI FRANCESCO·Filed 2009·Granted Apr 15, 2014·0 cites·16 claims
- 2545US2019275038A1Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2019·Application pending·0 cites
- 2644US11291674B2Arginase inhibitor combination therapiesCALITHERA BIOSCIENCES INC·Filed 2017·Granted Apr 5, 2022·0 cites·35 claims
- 2743US2020038398A1Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2018·Application pending·0 cites
- 2842US2017333430A1Combination therapy with glutaminase inhibitorsCALITHERA BIOSCIENCES INC·Filed 2017·Application pending·0 cites
- 2941US2014235548A1Compositions and methods for jamm protein inhibitionCLEAVE BIOSCIENCES INC·Filed 2012·Application pending·0 cites
- 3039US9359398B2Compounds for immunoproteasome inhibitionSHENK KEVIN D·Filed 2011·Granted Jun 7, 2016·0 cites·18 claims
- 3126US2015258082A1Combination therapy with glutaminase inhibitorsPARLATI FRANCESCO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francesco Parlati files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →